Free Trial

Palatin Technologies (PTN) Competitors

$0.22 -0.03 (-10.57%)
As of 04/17/2025

PTN vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Palatin Technologies stock or one of its competitors? The main competitors of Palatin Technologies include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Palatin Technologies vs.

Palatin Technologies (NYSE:PTN) and 180 Life Sciences (NASDAQ:ATNFW) are both manufacturing companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, community ranking, analyst recommendations and profitability.

Palatin Technologies and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Palatin TechnologiesOutperform Votes
No Votes
Underperform Votes
1
100.00%
180 Life SciencesN/AN/A

In the previous week, Palatin Technologies' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Palatin Technologies Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Palatin TechnologiesN/A N/A N/A
180 Life Sciences N/A N/A N/A

180 Life Sciences has lower revenue, but higher earnings than Palatin Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Palatin Technologies$350K16.35-$40.31M-$1.55-0.14
180 Life SciencesN/AN/AN/AN/AN/A

11.5% of Palatin Technologies shares are held by institutional investors. 7.1% of Palatin Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Palatin Technologies beats 180 Life Sciences on 3 of the 3 factors compared between the two stocks.

Get Palatin Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for PTN and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PTN vs. The Competition

MetricPalatin TechnologiesPharmaceutical Preparations IndustryManufacturing SectorNYSE Exchange
Market Cap$5.72M$6.46B$1.98B$18.41B
Dividend YieldN/A3.20%2.75%4.18%
P/E Ratio-0.146.9522.4131.09
Price / Sales16.35231.0362.0526.55
Price / CashN/A65.6751.7217.53
Price / BookN/A5.931.974.30
Net Income-$40.31M$143.22M-$385.85M$1.02B
1 Month PerformanceN/A-13.56%-5.55%-8.21%
1 Year PerformanceN/A-8.89%4.51%1.69%

Palatin Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PTN
Palatin Technologies
N/A$0.22
-10.6%
N/AN/A$5.72M$350,000.00-0.1430Analyst Forecast
Gap Up
High Trading Volume
ATNFW
180 Life Sciences
N/A$0.01
+3.9%
N/A-20.2%$0.00N/A0.007
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.02
-4.5%
N/A-79.0%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.08
+0.1%
N/A-2.0%$0.00$20,729.000.0040
ALVOW
Alvotech
N/A$1.11
flat
N/A-66.7%$0.00$489.68M0.004Negative News
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.03
flat
N/AN/A$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.07
+30.5%
N/AN/A$0.00$37.32M0.0070
BTMDW
biote
N/A$0.02
-34.7%
N/A-90.3%$0.00$197.19M0.00N/AGap Down
High Trading Volume
BCTXW
BriaCell Therapeutics
N/A$0.06
-32.2%
N/A-93.2%$0.00N/A0.008Gap Down
CELUW
Celularity
N/A$0.04
+0.3%
N/A+17.6%$0.00$48.20M0.00220

Related Companies and Tools


This page (NYSE:PTN) was last updated on 4/19/2025 by MarketBeat.com Staff
From Our Partners